Upharmacia May 2017
PHARMA MARKET NEWS
Gedeon Richter Ukraine Changed Organization Type and Replaced the Management
On May 5 , Gedeon Richter Ukraine changed the type of organization from Public JSC to Private JSC . Moreover , the Supervisory Board of the company decided to re-elect the management board of the company . Thus , Natalia Sereda replaced Lazslo Kovach at the position of the Head of the Board .
In 2016 , the sales of Gedeon Richter in Ukraine increased 11.3 % y-o-y to EUR 29.6 mio after in 2015 , the sales almost halved from EUR 55 mio in 2014 . In 2016 , the company lost 4 positions in the list of best-selling companies of the Ukrainian retail drug market and held 14th position .
Arterium May Increase Investment in Development
Arterium Corporation may increase investment in development of new preparations by 50-80 % in 2017 . In 2016 , Arterium invested UAH 106 mio in development . Currently , the Corporation has 80 preparations in development . The key directions of development are cardiology , neurology , gastroenterology and antibacterial agents .
Moreover , Arterium plans to expand the OTC business .
Arterium is implementing the strategy for accessing the EU market . The company has registered medicines in Serbia and plans to access Slovenia . In 2016 , Arterium Corporation held second place at the Ukrainian retail drug market climbing two positions as compared to 2015 .
Biofarma Disputes the
UNDR Tender
Ukrainian producer of blood preparations Biofarma seeks the UNDR to revise the tender on the procurement of blood factor XVIII , which was won by Italian company Kedrion . The President of Biofarma Kostiantyn Yefymenko stated that the Kedrion ’ s bid was 30 % more expensive than the proposition of Biofarma .
“ The MOH has all means to stop the tender and look into situation ,” Mr . Yefymenko said . “ We are ready figure this out at any level .” The company appealed to the UNDP for it to cancel the nontransparent decisions . It also requested the MOH of Ukraine to hold a joint meeting with representatives of the UNDP to review the results of the tender and to take measures to prevent similar situations in the future .
Assets of KVF
Increased 71 %
In 2016 , the net income of Kyiv Vitamin Factory ( KVF ) increased 35 % y-o-y to UAH 1.43 bn . The net profit of the company downed to UAH 145 mio form UAH 173 mio in 2015 . The value of the company ’ s assets increased 71 % y-o-y to UAH 1.09 bn . KVF is among the most dynamically developing companies on Ukrainian pharmaceutical market . In 2016 , it was the 9th company on the retail drug market improving the position from 11th place in 2015 and 14th in 2014 .
IPMA Signed Memorandum on Cooperation with Indian Pharmexcil
Indian Pharmaceutical Manufacturer ’ s Association ( IPMA ) of Ukraine signed Memorandum on cooperation with the Pharmaceuticals Export Promotion Council of India ( Pharmexcil ).
“ Our organizations will exchange information and organize joint events to promote the establishment of business relations between Ukraine and India ,” the Head of the IPMA said . “ After signing the Memorandum , the Indian company will be able to use organizational
6 www . upharma-c . com